Sensato Investors LLC Sells 25,300 Shares of Agilent Technologies, Inc. (A)
Sensato Investors LLC cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 80.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,100 shares of the medical research company’s stock after selling 25,300 shares during the quarter. Sensato Investors LLC’s holdings in Agilent Technologies were worth $362,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in A. Sun Life Financial INC boosted its holdings in Agilent Technologies by 26,144.4% during the second quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock valued at $140,000 after purchasing an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC boosted its holdings in Agilent Technologies by 92.3% during the second quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock valued at $148,000 after purchasing an additional 1,200 shares in the last quarter. Parallel Advisors LLC boosted its holdings in Agilent Technologies by 5.3% during the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after purchasing an additional 131 shares in the last quarter. Trust Co. of Vermont boosted its holdings in Agilent Technologies by 1.8% during the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock valued at $166,000 after purchasing an additional 50 shares in the last quarter. Finally, Fiduciary Trust Co. acquired a new stake in Agilent Technologies during the second quarter valued at approximately $186,000.
A number of research firms have weighed in on A. Wells Fargo & Company raised Agilent Technologies from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $42.92 to $60.73 in a report on Wednesday, July 12th. BidaskClub raised Agilent Technologies from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. Deutsche Bank AG set a $68.00 price objective on Agilent Technologies and gave the company a “buy” rating in a report on Wednesday, August 16th. Morgan Stanley lifted their price objective on Agilent Technologies from $76.00 to $86.00 and gave the company an “overweight” rating in a report on Friday. Finally, J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $70.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 16th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Agilent Technologies has an average rating of “Buy” and a consensus target price of $65.62.
In other Agilent Technologies news, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total value of $306,300.00. Following the sale, the insider now owns 45,138 shares in the company, valued at $2,765,153.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mark Doak sold 12,421 shares of the firm’s stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $61.57, for a total transaction of $764,760.97. The disclosure for this sale can be found here. Insiders sold 170,720 shares of company stock worth $10,795,039 in the last 90 days.
Agilent Technologies, Inc. (NYSE:A) traded up 0.75% on Friday, reaching $66.19. 228,548 shares of the company traded hands. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $66.45. The stock has a 50-day moving average of $64.47 and a 200 day moving average of $59.32. The company has a market capitalization of $21.30 billion, a PE ratio of 34.14 and a beta of 1.30.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same quarter last year, the business posted $0.49 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. On average, equities analysts forecast that Agilent Technologies, Inc. will post $2.32 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd will be given a $0.132 dividend. The ex-dividend date is Monday, October 2nd. This represents a $0.53 dividend on an annualized basis and a yield of 0.80%. Agilent Technologies’s dividend payout ratio is currently 27.32%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.